sur THERACLION (EPA:ALTHE)
Theraclion Reorganizes its Board of Directors
On June 18, 2026, Theraclion announced the reorganization of its Board of Directors. Yann Duchesne, Chairman and Director since January 2022, decided not to continue his term. Shareholders elected a new board composed of five members: Lijuan Deng, Claude Lenoir, Cédric Bellanger, Mehdi El Glaoui, and Vincent Gardès. Gardès joins the board after having served as an observer.
Claude Lenoir has been appointed interim President to ensure continuity of governance. Martin Deterre, CEO, expressed his gratitude to Yann Duchesne for his essential contributions to the company's strategic development. Theraclion, a MedTech specialist, continues its growth under this new leadership.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de THERACLION